Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Lynn Rochester

Newcastle AuthorsTitleYearFull text
Dr Pat McCue
Dr Lisa Shaw
Dr Silvia Del Din
Dr Susan Lord
Dr Christopher Price
et al.		Acceptability and deliverability of an auditory rhythmical cueing (ARC) training programme for use at home and outdoors to improve gait and physical activity post-stroke2022
Dr Christopher Hurst
Professor Sian Robinson
Professor Miles Witham
Dr Richard Dodds
Dr Antoneta Granic
et al.		Resistance exercise as a treatment for sarcopenia: prescription and delivery2022
Dr Jenni Naisby
Dr Alison Yarnall
Professor Lynn Rochester
Professor Richard Walker
A Survey of People With Parkinson’s and Their Carers: The Management of Pain in Parkinson’s 2021
Dr Ríona McArdle
Steph Pratt
Dr Chris Buckley
Dr Silvia Del Din
Dr Brook Galna
et al.		Balance Impairments as Differential Markers of Dementia Disease Subtype2021
Diego Orcioli Da Silva
Aisha Islam
Dr Mark Baker
Professor Lynn Rochester
Dr Annette Pantall
et al.		Bi-Anodal Transcranial Direct Current Stimulation Combined with Treadmill Walking Decreases Motor Cortical Activity in Young and Older Adults2021
Dr Silvia Del Din
Cameron Kirk
Dr Alison Yarnall
Professor Lynn Rochester
Body-Worn Sensors for Remote Monitoring of Parkinson’s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead2021
Joanna Wilson
Dr Alison Yarnall
Dr Brook Galna
Dr Rachael Lawson
Dr Lisa Alcock
et al.		Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease2021
Dr Silvia Del Din
Professor Lynn Rochester
Consensus based framework for digital mobility monitoring2021
Professor Lynn Rochester
Dr Silvia Del Din
Detecting sensitive mobility features for Parkinson disease stages via machine learning2021
Dr Silvia Del Din
Dr Alison Yarnall
Professor Lynn Rochester
Exenatide once weekly over 2 years as a potential disease modifying treatment for Parkinson's disease: protocol for a multi-centre, randomised, double blind, parallel group, placebo controlled, Phase 3 trial, The 'Exenatide-PD3' study2021
1234567891011121314151617181920...